Stay updated with breaking news from Science Driven. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval ST. LOUIS, Nov. 16, 2022 /PRNewswire/
Growers often unknowingly limit yield potential with their nitrogen source choices. In cool conditions, not all nitrogen sources are available during this critical growth stage. The addition of soluble calcium during spring applications improves root growth and sets the crop up for improved yields this fall.
DGAP-News: Heidelberg Pharma AG / Key word(s): Alliance28.02.2022 / 07:04 The issuer is solely responsible for the content of this announcement.PRESS RELEASEHeidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment- Heidelberg Pharma grants Huadong exclusive license to develop and com...
Heidelberg Pharma grants Huadong exclusive license to develop and commercialize HDP-101 and HDP-103 in Asia [1] (excluding Japan), plus exclusive opt-in rights for two more pipeline candidates, with a
DGAP-News: Heidelberg Pharma AG / Key word(s): Alliance Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equit...